GFS Advisors »

Intellia Therapeutics shares owned by GFS Advisors

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by GFS Advisors from 13F filings

Historical chart of GFS Advisors investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by GFS Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by GFS Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $5.8M 130 44731.87

More positions owned by GFS Advisors

Cardinal Health (CAH)
Byline Ban (BY)
HEICO Corporation (HEI)
Alphabet Cap Stk Cl A (GOOGL)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Spdr Series Trust St Str Sp500div (SPYD)
United Parcel Svcs CL B (UPS)
Tesla Motors (TSLA)
Ishares Tr Msci Eafe Etf (EFA)
Ishares Tr Msci Acwi Etf (ACWI)
Microsoft Corporation (MSFT)
Micron Technology (MU)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ecopetrol S A Sponsored Ads (EC)
Walt Disney Company (DIS)

View all positions for GFS Advisors

Top funds holding Intellia Therapeutics

ARK Investment Management
BlackRock
Vanguard Portfolio Management
State Street Corporation
D. E. Shaw & Co
Vanguard Capital Management
Two Sigma Investments
FMR
RA Capital Management
Regeneron Pharmaceuticals
Geode Capital Management
Arrowstreet Capital, Limited Partnership
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Dimensional Fund Advisors

View all funds holding Intellia Therapeutics